{"id":521161,"date":"2021-08-02T08:04:00","date_gmt":"2021-08-02T12:04:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/"},"modified":"2021-08-02T08:04:00","modified_gmt":"2021-08-02T12:04:00","slug":"selecta-biosciences-to-participate-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/","title":{"rendered":"Selecta Biosciences to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">WATERTOWN, Mass., Aug.  02, 2021  (GLOBE NEWSWIRE) &#8212; Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR\u2122 platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Selecta\u2019s Chief Executive Officer, Carsten Brunn, Ph.D., will participate in upcoming investor conferences in August.<\/p>\n<p>Details on the panel can be found below.<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>BTIG Virtual Biotechnology Conference 2021<\/strong><br \/>\n          <br \/>Format: Fireside chat and one-on-one investor meetings<br \/>Date: Monday, August 9, 2021<br \/>Presentation Time: 3:00 p.m. EDT<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Canaccord Genuity 41<\/strong><br \/>\n          <sup><br \/>\n            <strong>st<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Growth Conference <\/strong><br \/>\n          <br \/>Format: Fireside chat and one-on-one investor meetings<br \/>Date: Wednesday, August 11, 2021<br \/>Presentation Time: 9:30 a.m. EDT<br \/>Webcast: <a href=\"https:\/\/wsw.com\/webcast\/canaccord60\/selb\/2433112\" rel=\"nofollow noopener\" target=\"_blank\">Click Here<\/a><\/li>\n<\/ul>\n<p>BTIG hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, please contact your BTIG representative. An archived webcast of the Canaccord corporate update will be accessible in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n86C54FsUAT2XMJnJ0H4P_UMv9O6G4fn5q4N9HsxCqunDkX8wVQ6Kpq6RV8t5RtFx0ylKNLI6rGM-x5Uv_2VazI-vE-5_A8sqEM5YOY1-qY=\" rel=\"nofollow noopener\" target=\"_blank\">Investors &amp; Media<\/a> section of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0NUYBj4LqAM3Z7hmgzpCe5_cesZTbbmHMt4DdcgSJoQ20NnjqUJ3H9U3CrA-bC6-QOEne4R8toYC0Gk6LrkwNObxglVt0MtArxO2vADYL58=\" rel=\"nofollow noopener\" target=\"_blank\">www.selectabio.com<\/a>.<\/p>\n<p>\n        <strong>About\u00a0Selecta Biosciences, Inc.<\/strong><br \/>\n        <br \/>Selecta Biosciences Inc.\u00a0(NASDAQ: SELB) is a clinical stage biotechnology company leveraging its ImmTOR\u2122 platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses. With a proven ability to induce tolerance to highly immunogenic proteins, ImmTOR has the potential to amplify the efficacy of biologic therapies, including redosing of life-saving gene therapies, as well as restore the body\u2019s natural self-tolerance in autoimmune diseases.\u00a0Selecta\u00a0has several proprietary and partnered programs in its pipeline focused on enzyme therapies, gene therapies, and autoimmune diseases.\u00a0Selecta Biosciences\u00a0is headquartered in the\u00a0Greater Boston\u00a0area. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0NUYBj4LqAM3Z7hmgzpCe-3yCLsV4lGXT64UfrbMlWZi47DrVB5EsgebQ4OeC_y2RkwJ0Kwas76OXioEbfxf7omDdjukzTW6OpVNGsf3pEnG1DGtAh-zWlnna24WSTvVwlpxu9cxrg-1lHatys4Z-R_bZqxPcTFhDBqvIf2VNeU-MC6HYCHDm8mXYSJt2ChEGSlq4drv4iSBNTV0ckZvXerfg7Vhoy5268JU4R4erxRXO-TOF2A8Vj2IDto4KAmT5rcWmBSAX40igDZcccrphsUZobR0m6a2VSnrX6slxqM5I1UlT2AoZ-afmjJ4LRIYYInZ35Cyaq-iPxmjEjaaZbvSj2fYAlu8Q_rGL2B3ZN83sxXd8viQnM6j7VNzhrrtjeQoxftZI_q_1lOi7zJQM1sK3W0PpSwyvXBcqL8NaYj6ZUQiGsQ_iuOwfxNFN8Y7JFXRovnq7kBTSMFLmG74WlBmkqTFa4gyr5SxLEoJtT1Xqd9gjz6kt852bp0-rZdcmFw97XwcS0DMCjS7MWlXWA9oSzIWhid8Bt9WI_0N2CR8_5e-TiJVGhHoSQPbNnfsiVNi48p6SHpASF9cq_YQW-FcqJJCiw9aQEdmXv8A6NVgQBbIoYnR1PrLO409axYQChgGiBq18Xpjuc_uA8cMhkKUBVNTTpdWkJK6Zm2W8KlvFLBVBzjij8Y2cAW-Wn5jOyVcjU8Ge-RfpD_4Hd9jX8VBHjoaNJaunr2PGkpS3KufCUvlAnqFukS6WSIDPwIbjKVddc-_SIMpWUIUH3UnxOdYNipAqAqXaASkE7c4s6p_DW9O5DhxbNMq_m176wMVlLcFJdxv9uj1ITMSEWEtceu-IwilFCZoAAbR2lGQpJCNE-tU5C4iTP5Rn2rcFXhMb29yrvQyWytoV_Ggvn-7qU-r15rSyt374A6WmMth79k3tfU-LJqIAFk8G7dC25_PswDsvhOGeKonpgnmQ-JIBcUMMEdN3qyDMhqYEbgTJuXR8G5IRB1j15vB51gYddnOSrVnlmmiXu00Jb6ZWDfgSJcuh1W6HF-JaTYEbR8IVAhdlf5OssR6pnH9GmrQG9cYCAsypIASf5NhoMUSugnqhbfXDxwTnDpJXbpJvtWGbsVLqY88XUPhfufeIu4BepZIh6jBsfLCDbiGbwuct6yzyOT1uETI3tOVSclt3-l2VrUpFFfxQLnNkRuyIk-BB1wysX_nEEMjk6ny3n3_UlBLXF2znJDf0zcV8_q7C9_2il1ehUGuMls8F705bWru_m7tPO7XzkTwjabn-3jd8JHheL-dnaWTZRkrNmBq60_VtoPK8HXjqMZRimVCKprrre5cre0FUcdxmZAnMQnkjuUh6TXs6WaLpDskyh5ACiwwb7ZqShicb6n6es6GBiFwIczc\" rel=\"nofollow noopener\" target=\"_blank\">www.selectabio.com<\/a>.<\/p>\n<p>\n        <strong>For Investors:<\/strong><br \/>\n        <br \/>Bruce Mackle<br \/>LifeSci Advisors, LLC<br \/>+1-929-469-3859<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=b-yCBYCmIY2ro8DOyOBBQS_uUwHlpZ8wYpolCGbj1Te1k6zJ6QGEIJdh6oEHDPtMK7vVRNxYg7Cwfdjl--m4FB994IPVh0RhCx2ZSkaGnIZG_yIIjJ6kLM9Br3Gr-GiB\" rel=\"nofollow noopener\" target=\"_blank\">bmackle@lifesciadvisors.com<\/a><\/p>\n<p>\n        <strong>For Media:\u00a0<\/strong><br \/>\n        <br \/>Brittany Leigh, Ph.D.<br \/>LifeSci Communications, LLC<br \/>+1-646-751-4366<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7fUSmP-mRKw99XRBOBrZgZhbGMkj5mYREt2cYMT-93dNhnHU49ej9Dag0_dYaqawa976rD2F0QjUv23Qqoc6I1jRAN2QTjfcOk4eFTolaSY=\" rel=\"nofollow noopener\" target=\"_blank\">bleigh@lifescicomms.com<\/a>\u00a0<\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4ODgzNCM0MzIwMzI2IzUwMDA3NjYxMA==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/8376a79c-1fe6-4e20-adc7-3c104c3faf42\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) &#8212; Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR\u2122 platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Selecta\u2019s Chief Executive Officer, Carsten Brunn, Ph.D., will participate in upcoming investor conferences in August. Details on the panel can be found below. BTIG Virtual Biotechnology Conference 2021 Format: Fireside chat and one-on-one investor meetingsDate: Monday, August 9, 2021Presentation Time: 3:00 p.m. EDT Canaccord Genuity 41 st Annual Growth Conference Format: Fireside chat and one-on-one investor meetingsDate: Wednesday, August 11, 2021Presentation Time: 9:30 a.m. EDTWebcast: Click Here BTIG hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Selecta Biosciences to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-521161","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Selecta Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Selecta Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) &#8212; Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR\u2122 platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Selecta\u2019s Chief Executive Officer, Carsten Brunn, Ph.D., will participate in upcoming investor conferences in August. Details on the panel can be found below. BTIG Virtual Biotechnology Conference 2021 Format: Fireside chat and one-on-one investor meetingsDate: Monday, August 9, 2021Presentation Time: 3:00 p.m. EDT Canaccord Genuity 41 st Annual Growth Conference Format: Fireside chat and one-on-one investor meetingsDate: Wednesday, August 11, 2021Presentation Time: 9:30 a.m. EDTWebcast: Click Here BTIG hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, &hellip; Continue reading &quot;Selecta Biosciences to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-02T12:04:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4ODgzNCM0MzIwMzI2IzUwMDA3NjYxMA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Selecta Biosciences to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2021-08-02T12:04:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\\\/\"},\"wordCount\":287,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4ODgzNCM0MzIwMzI2IzUwMDA3NjYxMA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\\\/\",\"name\":\"Selecta Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4ODgzNCM0MzIwMzI2IzUwMDA3NjYxMA==\",\"datePublished\":\"2021-08-02T12:04:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4ODgzNCM0MzIwMzI2IzUwMDA3NjYxMA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4ODgzNCM0MzIwMzI2IzUwMDA3NjYxMA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Selecta Biosciences to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Selecta Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Selecta Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"WATERTOWN, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) &#8212; Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR\u2122 platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Selecta\u2019s Chief Executive Officer, Carsten Brunn, Ph.D., will participate in upcoming investor conferences in August. Details on the panel can be found below. BTIG Virtual Biotechnology Conference 2021 Format: Fireside chat and one-on-one investor meetingsDate: Monday, August 9, 2021Presentation Time: 3:00 p.m. EDT Canaccord Genuity 41 st Annual Growth Conference Format: Fireside chat and one-on-one investor meetingsDate: Wednesday, August 11, 2021Presentation Time: 9:30 a.m. EDTWebcast: Click Here BTIG hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, &hellip; Continue reading \"Selecta Biosciences to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-02T12:04:00+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4ODgzNCM0MzIwMzI2IzUwMDA3NjYxMA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Selecta Biosciences to Participate in Upcoming Investor Conferences","datePublished":"2021-08-02T12:04:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/"},"wordCount":287,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4ODgzNCM0MzIwMzI2IzUwMDA3NjYxMA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/","name":"Selecta Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4ODgzNCM0MzIwMzI2IzUwMDA3NjYxMA==","datePublished":"2021-08-02T12:04:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4ODgzNCM0MzIwMzI2IzUwMDA3NjYxMA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4ODgzNCM0MzIwMzI2IzUwMDA3NjYxMA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/selecta-biosciences-to-participate-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Selecta Biosciences to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/521161","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=521161"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/521161\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=521161"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=521161"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=521161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}